Skip to content

Intercostal Cryoanalgesia for Chronic Pain After VATS Lung Resection

Intercostal Cryoanalgesia for Prevention of Chronic Postoperative Pain Following Video-assisted Thoracoscopic Lung Cancer Resection

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05884099
Acronym
CRYO-VATS-2
Enrollment
80
Registered
2023-06-01
Start date
2023-11-09
Completion date
2025-04-21
Last updated
2025-07-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain, Cryotherapy Effect, Lung Cancer, Surgery

Brief summary

Intercostal cryoanalgesia is a technique that allows extensive and prolonged analgesia of the hemithorax. The aim of this study is to demonstrate the efficacy of intercostal cryoanalgesia as an adjunct to a single-injection paravertebral block for the prevention of chronic thoracic pain after VATS lung resection surgery.

Detailed description

VATS lung resection is associated with a high incidence of persistent thoracic pain. To our knowledge, there is no study on the effect of cryoanalgesia on the incidence and severity of chronic thoracic pain 3 months after VATS lung resection. Intercostal cryoanalgesia is a technique that allows extensive and prolonged analgesia of the hemithorax. In a recent study by Ilfeld & al, intercostal cryoanalgesia (combined with a single-injection paravertebral block) was able to drastically lower the incidence of chronic pain after total mastectomy compared to the use of the paravertebral block alone (3% vs 17%). The aim of this study is to demonstrate the efficacy of intercostal cryoanalgesia for the prevention of chronic thoracic pain after VATS lung resection surgery.

Interventions

CO2 Cryoanalgesia AND paravertebral block with Bupivacaine 0.5%

Paravertebral block with Bupivacaine 0.5%

Sponsors

Centre hospitalier de l'Université de Montréal (CHUM)
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

Quadruple

Intervention model description

Intervention : intercostal cryoanalgesia + single-injection paravertebral block Control group : single-injection paravertebral block

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients scheduled for elective anatomical pulmonary resection (anatomical segmentectomy, lobectomy or bilobectomy) by VATS for lung cancer * American Society of Anesthesiologists (ASA) score 1-3

Exclusion criteria

* Contraindication to the paravertebral block (coagulopathy, discontinuous paravertebral space, impossible thoracoscopic visualization of the paravertebral space) * Contraindication to intercostal cryoanalgesia (cold urticaria, cryoglobulinemia) * Epidural analgesia preferred (high risk of thoracotomy, marginal lung function) * Surgical criteria (conversion to thoracotomy, non anatomical wedge resection) * Preoperative thoracic or shoulder pain on the operated side * Known allergy to acetaminophen, celecoxib, sulfa, or both hydromorphone and morphine * History of thoracic surgery on the operated site * Regular use of opioids or medication with effects against neuropathic pain (tricyclics, gabapentinoids, duloxetine, venlafaxine) * Inability to understand pain scales or to communicate clearly despite adequate teaching * Contraindication to non-steroidal anti-inflammatory drugs (renal filtration rate \< 60 mL/min, active gastric ulcer) * Pregnancy * Patient refusal to participate

Design outcomes

Primary

MeasureTime frameDescription
Incidence of persistent thoracic pain3 monthsPersistent postoperative thoracic pain (yes or no)

Secondary

MeasureTime frameDescription
Severity of persistent thoracic pain1,3 and 6 monthsNumerical Rating Scale (NRS) score : scale 0 (no pain) to 10 (worst), at rest and during cough
Incidence of persistent opioid consumption1,3 and 6 monthsPersistent postoperative opioid consumption (yes/no)
Incidence of persistent thoracic pain1 and 6 monthsPersistent postoperative thoracic pain (yes or no)
Incidence of new prescription for neuropathic pain medication1, 3 and 6 monthsYes or no
Persistent hypoesthesia over the ipsilateral thorax1 and 6 monthsEvaluation of the dermatomal levels of hypoesthesia using a Von Frey monofilament as well as the subjective presence of a sensation of hypoesthesia.
Incidence of postoperative neuropathic pain48 hours, 1 month and 6 monthsDN4 score (10 points) ; positive if 4 points or more

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026